当前位置: 首页 > 期刊 > 《中华现代外科学杂志》 > 2006年第6期
编号:11023987
前列腺癌内分泌治疗对血PSA的影响及其临床意义
http://www.100md.com 《中华现代外科学杂志》 2006年第6期
前列腺肿瘤;癌;前列腺特异性抗原,,前列腺肿瘤;癌;前列腺特异性抗原,1资料与方法,2结果,3讨论,【参考文献】
     【摘要】 目的 探讨进展期前列腺癌(PCa)患者内分泌治疗前后前列腺特异性抗原(PSA)变化的临床意义。方法 测定PCa患者内分泌治疗前和治疗后3、6、12、24个月血清PSA。结果 治疗后3个月与治疗前相比血清PSA下降明显。治疗后6个月达到PSA谷值。结论 血清PSA可作为判断PCa内分泌治疗效果的标准,血清PSA再次升高(>4ng/ml)提示肿瘤发展为非激素依赖性前列腺癌,是预测生存率的一个独立因素。

    【关键词】 前列腺肿瘤;癌;前列腺特异性抗原

    The significance of the changing of serum PSA after endocrinotherapy in advanced prostatic cancer

    ZHU Hongxiang,QIAN Xiongyan,CHEN Shugen,et al.Department of Urology,Luodian Hospital,Shanghai 201908,China

    【Abstract】 Objective To detect the changing of the serum PSA in patients with advanced prostatic cancer,and to discuss its significance.Methods A total of 86 consecutive advanced prostate cancer patients treated with antiandrogen medications 24 months after castration were enrolled.Serum levels of prostatic specific antigen(PSA) were obtained just prior to castration,and 3,6,12,24 months after castration.Results 3 months after treatment the serum PSA reduced obviously than it before treatment.6 months after treatment the serum PSA value was in the lowest.Conclusion The serum PSA can be a standard which judge the effect of endocrinotherapy in PCa,and be a very useful prognostic marker.PSA>4ng/ml showed the disease had developed to the hormone refractory PCa. ......

您现在查看是摘要页,全文长 6028 字符